Trial
NCT03266900
A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
Bladder Cancer Canada; Canadian Urological Association; Canadian Urologic Oncology Group
Condition
Bladder Cancer
Intervention
re-TURBT
Why stopped
Difficulties with accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-20